
    
      This is a multicenter, randomized, parallel group, double-masked, active- controlled study.
      Subjects will be enrolled and randomized to either 8 % or 15% DSP-Visulex with placebo drops
      or Vehicle-Visulex (V-Visulex) with prednisolone acetate 1% eye drops. All subjects will
      receive concomitant treatment with cyclopentolate.
    
  